Keynote 

Robert S. Langer, ScD
David H. Koch Institute Professor at the Massachusetts Institute of Technology (MIT)

Website: https://langerlab.mit.edu/langer-bio/

Biomaterials & Biotechnology: From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering

Advanced drug delivery systems are having an enormous impact on human health. We start by discussing our early research on developing the first controlled release systems for macromolecules and the isolation of angiogenesis inhibitors and how these led to numerous new therapies. This early research then led to new drug delivery technologies including nanoparticles and nanotechnology that are now being studied for use treating cancer, other illnesses and in vaccine delivery (including the Covid-19 vaccine). Approaches for synthesizing new biomaterials, such as biodegradable polyanhydrides, are then examined, and examples where such materials are used in brain cancer and other diseases are discussed. Finally, by combining mammalian cells, including stem cells, with synthetic polymers, new approaches for engineering tissues are being developed that may someday help in various diseases. Examples in the areas of cartilage, skin, blood vessels and heart tissue are discussed.

Presented by the Center for Bionanoengineering